Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Royal Adelaide Hospital
Research demonstrates that TB-500 administration mobilizes EPCs from bone marrow reservoirs, with animal studies showing 3-fold increases in circulating EPC numbers that contribute to neovascularization through both structural incorporation into developing vessels and paracrine secretion of pro-angiogenic factors
The difference between BAC and impairment can be attributed to how alcohol affects the brain and body
AOD 9604 and Research in Cancer Cells The peptide may be able to bind (target) tumor-related proteins to enhance tumor drug accumulation and local cytotoxicity
As of May 2026, neither BPC-157 nor TB-500 holds an MHRA product licence as a medicinal product for human use in the United Kingdom, and neither appears on the MHRA's registered products database [1][2]
US$ 22.16
US$ 26.71
US$ 29.94
US$ 27.30
